(1)
CLINICAL AND IMMUNOBIOCHEMICAL MARKERS IN THE DIAGNOSIS OF BRONCHIAL ASTHMA COMBINED WITH TYPE 2 DIABETES MELLITUS. Web sci. scholars 2025, 3 (11), 6-16.